(Q72234130)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

L Bergman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

J A van Dongen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

B van Ooijen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

F E van Leeuwen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 April 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

77-83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00666494

25 October 2019

exact match

0 references

cites work

Primary treatment of breast cancer in elderly women with Tamoxifen

1 reference

12 December 2020

Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen only

1 reference

12 December 2020

Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast

1 reference

12 December 2020

Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer

1 reference

12 December 2020

Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation

1 reference

12 December 2020

Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up

1 reference

12 December 2020

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

12 December 2020

A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patients.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00666494

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7749163%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference